BOT 2.82% 34.5¢ botanix pharmaceuticals ltd

Ann: Botanix $40 Million US Lead Placement and Management Update, page-105

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,073 Posts.
    lightbulb Created with Sketch. 1452
    There is always that bit of uncertainty surrounding a CR and we all have been there. But what you find is that if you went away for a while, had some bacon, eggs and toast and about fifteen coffees in the meantime and came back, nothing had changed. Except your mettle and I am not talking about steel here. This raise contrary to Jala's respected opinion previoulsy has actually added value to us as can be seen by the best ever closing price. I mean hello. Did most of us think we would be infront today? No. But most of us are focused, or should i say, will not only be focused on the acne results but what is coming in the next 4 weeks and we also have another piss up for matt to get involved with at that conference. Rack up the frequent flyer points Matt but just don't sit at the pointy part of the plane just yet.

    Rusty great work and the interview i really liked was the Finance News interview. Remember Nostradamus so excited about his new position and the opportunities. I don't know what they all are smoking or snorting in that filly office, could be good old Vicks vaporub for all I know, but they all come out and say things pretending to be soothsayers. Try getting Ita Buttrose to say in front of you that without spraying you with a mouth of saliva. Zeuth thayers pleeze Ita. And Matt has told us what is going on with the Intellectual Property (IP) as time moves on. I had alluded to big pharmas Keytruda, a monster of a cancer drug. Did you know that to get this approved for all the six hundred and thirty three cancers, I made that up, but to get an approval for a single cancer needs a bit of work. But now Keytruda is one drug treating plenty of cancers. We have one drug treating plenty of conditions. The new appointees on the board know that. The ten new investees who probably will make the top 20 book know that. I hope all of us shareholders know that. Our CBD will become a behemoth. No doubt about that as the patent attorney, matt has done his due diligence, and tied that up nicely.

    I love the garden of eden analogy that Matt used. Some good quality stuff getting jam packed in somebodys bong i reckon. Can you go back to billie jean king and elton johns song philadelpha freedom. Someone mentioned that Matt had a slight rosacea issue on his chin. Well his eyes certainly are not bloodshot. Could be the blue boxed Clear Eyes that folks use. Back to the garden where Matt said that that the opportunities with CBD are like low hanging fruit. Now I am glad this is the garden of eden in america not the garden of eden in darlinghurst where i wouldnt be touching any low hanging fruit. But in america, Matt is going to leverage the full benefits of the cbd molecule and allow BOT to create...wait for it...a portfolio of products that ultimately will deliver a lot of value to shareholders.

    Free carry at any stage is something that a smart person would consider but selling at 44c would put more of a smile on your face I am sure.

    With so much to be announced in the near future, many of us will now continue to have smiles on our dials. This would not have been achieved without two things. Firstly the determination of the Board to start with the two phase twos extremely quickly much to many of our dismay at the time and that bent over the table feeling we all had without getting paid for it, and secondly, the actual efficacy results we have seen scientifically.

    She'a a pulsating, she's rehearsing. Just got's to keep working on jala's cursing.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.010(2.82%)
Mkt cap ! $631.5M
Open High Low Value Volume
35.0¢ 35.3¢ 34.5¢ $454.3K 1.308M

Buyers (Bids)

No. Vol. Price($)
13 276361 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 478992 45
View Market Depth
Last trade - 15.15pm 01/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.